A Xenograft Model for Venous Malformation.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2021
Historique:
entrez: 6 8 2020
pubmed: 6 8 2020
medline: 26 3 2021
Statut: ppublish

Résumé

Xenograft models allow for an in vivo approach to monitor cellular functions within the context of a host microenvironment. Here we describe a protocol to generate a xenograft model of venous malformation (VM) based on the use of human umbilical vein endothelial cells (HUVEC) expressing a constitutive active form of the endothelial tyrosine kinase receptor TEK (TIE2 p.L914F) or patient-derived EC containing TIE2 and/or PIK3CA gene mutations. Hyperactive somatic TIE2 and PIK3CA mutations are a common hallmark of VM in patient lesions. The EC are injected subcutaneously on the back of athymic nude mice to generate ectatic vascular channels and recapitulate histopathological features of VM patient tissue histology. Lesion plugs with TIE2/PIK3CA-mutant EC are visibly vascularized within 7-9 days of subcutaneous injection, making this a great tool to study venous malformation.

Identifiants

pubmed: 32754818
doi: 10.1007/978-1-0716-0916-3_13
pmc: PMC7444280
mid: NIHMS1618391
doi:

Substances chimiques

Class I Phosphatidylinositol 3-Kinases EC 2.7.1.137
Receptor, TIE-2 EC 2.7.10.1

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

179-192

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL117952
Pays : United States

Références

Blood. 2007 Jun 1;109(11):4761-8
pubmed: 17327403
Circ Res. 2008 Jul 18;103(2):194-202
pubmed: 18556575
J Tissue Eng Regen Med. 2015 May;9(5):632-6
pubmed: 23955835
Cell. 1996 Dec 27;87(7):1181-90
pubmed: 8980225
Cell Death Dis. 2018 Jan 19;9(2):45
pubmed: 29352118
Blood. 2009 Jul 9;114(2):237-47
pubmed: 19339693
Cells. 2019 Aug 13;8(8):
pubmed: 31412684
Nature. 2018 Jun;558(7711):540-546
pubmed: 29899452
Hum Mol Genet. 2007 Oct 15;16 Spec No. 2:R140-9
pubmed: 17670762
Nat Biomed Eng. 2017;1:
pubmed: 28868207
Sci Transl Med. 2016 Mar 30;8(332):332ra43
pubmed: 27030595
Phlebology. 2010 Oct;25(5):224-35
pubmed: 20870869
Angiogenesis. 2018 Nov;21(4):725-735
pubmed: 29786783
J Exp Med. 2019 Feb 4;216(2):407-418
pubmed: 30591517
Angiogenesis. 2018 May;21(2):363-380
pubmed: 29460088
Cold Spring Harb Protoc. 2019 Nov 1;2019(11):
pubmed: 31676576
Int J Med Sci. 2018 Feb 12;15(4):385-394
pubmed: 29511374
J Clin Invest. 2015 Sep;125(9):3491-504
pubmed: 26258417
Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):496-512
pubmed: 30626204
J Tissue Eng Regen Med. 2011 Apr;5(4):e74-86
pubmed: 21413157
Nat Rev Cancer. 2017 Apr;17(4):254-268
pubmed: 28104906
Cell. 1996 Dec 27;87(7):1153-5
pubmed: 8980221
Sci Transl Med. 2016 Mar 30;8(332):332ra42
pubmed: 27030594

Auteurs

Jillian Goines (J)

Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Elisa Boscolo (E)

Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. elisa.boscolo@cchmc.org.
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA. elisa.boscolo@cchmc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH